Wellington Shields & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $753K | Sell |
5,963
-47
| -0.8% | -$6.19K | 0.17% | 119 |
|
|
2026
Q1 | $838K | Buy |
6,010
+240
| +4% | +$33.6K | 0.21% | 98 |
|
|
2025
Q4 | $708K | Sell |
5,770
-35
| -0.6% | -$4.25K | 0.17% | 109 |
|
|
2025
Q3 | $644K | Hold |
5,805
| – | – | 0.17% | 118 |
|
|
2025
Q2 | $644K | Hold |
5,805
| – | – | 0.18% | 115 |
|
|
2025
Q1 | $650K | Buy |
5,805
+4
| +0.1% | +$413 | 0.2% | 111 |
|
|
2024
Q4 | $536K | Hold |
5,801
| – | – | 0.16% | 123 |
|
|
2024
Q3 | $486K | Sell |
5,801
-468
| -7% | -$35.7K | 0.15% | 127 |
|
|
2024
Q2 | $430K | Sell |
6,269
-61
| -1% | -$4.07K | 0.14% | 130 |
|
|
2024
Q1 | $464K | Sell |
6,330
-686
| -10% | -$52.8K | 0.16% | 123 |
|
|
2023
Q4 | $568K | Buy |
7,016
+18
| +0.3% | +$1.4K | 0.21% | 105 |
|
|
2023
Q3 | $524K | Sell |
6,998
-900
| -11% | -$69.2K | 0.13% | 114 |
|
|
2023
Q2 | $609K | Sell |
7,898
-200
| -2% | -$16K | 0.14% | 101 |
|
|
2023
Q1 | $672K | Sell |
8,098
-500
| -6% | -$41.4K | 0.15% | 90 |
|
|
2022
Q4 | $738K | Sell |
8,598
-818
| -9% | -$64.8K | 0.17% | 80 |
|
|
2022
Q3 | $581K | Buy |
9,416
+149
| +2% | +$9.4K | 0.25% | 93 |
|
|
2022
Q2 | $573K | Sell |
9,267
-50
| -0.5% | -$3.1K | 0.14% | 98 |
|
|
2022
Q1 | $554K | Buy |
9,317
+29
| +0.3% | +$1.85K | 0.18% | 117 |
|
|
2021
Q4 | $674K | Sell |
9,288
-1,003
| -10% | -$69.1K | 0.13% | 100 |
|
|
2021
Q3 | $719K | Buy |
10,291
+1,972
| +24% | +$139K | 0.25% | 86 |
|
|
2021
Q2 | $573K | Buy |
8,319
+165
| +2% | +$11K | 0.19% | 103 |
|
|
2021
Q1 | $527K | Buy |
8,154
+680
| +9% | +$43.8K | 0.19% | 103 |
|
|
2020
Q4 | $435K | Sell |
7,474
-1,231
| -14% | -$74.3K | 0.16% | 109 |
|
|
2020
Q3 | $550K | Buy |
8,705
+1,405
| +19% | +$97.4K | 0.23% | 85 |
|
|
2020
Q2 | $562K | Sell |
7,300
-3,550
| -33% | -$272K | 0.25% | 83 |
|
|
2020
Q1 | $811K | Sell |
10,850
-1,600
| -13% | -$111K | 0.45% | 61 |
|
|
2019
Q4 | $809K | Buy |
+12,450
| New | +$811K | 0.36% | 78 |
|
|
2019
Q3 | – | Sell |
-13,550
| Closed | -$915K | – | 139 |
|
|
2019
Q2 | $915K | Buy |
13,550
+850
| +7% | +$55.9K | 0.43% | 64 |
|
|
2019
Q1 | $826K | Buy |
12,700
+2,400
| +23% | +$160K | 0.42% | 67 |
|
|
2018
Q4 | $644K | Buy |
+10,300
| New | +$720K | 0.37% | 75 |
|
|
2015
Q3 | – | Sell |
-1,900
| Closed | -$222K | – | 100 |
|
|
2015
Q2 | $222K | Buy |
+1,900
| New | +$208K | 0.07% | 91 |
|
|
2015
Q1 | – | Sell |
-2,300
| Closed | -$217K | – | 111 |
|
|
2014
Q4 | $217K | Hold |
2,300
| – | – | 0.12% | 99 |
|
|
2014
Q3 | $245K | Sell |
2,300
-425
| -16% | -$41.6K | 0.15% | 90 |
|
|
2014
Q2 | $226K | Buy |
+2,725
| New | +$212K | 0.14% | 99 |
|
Other funds holding GILD
Wellington Shields & Co's GILD Position: Q2 2026 in Review
Wellington Shields & Co reduced its Gilead Sciences (GILD) stake by 0.78% in Q2 2026, selling an estimated $6.19K and leaving 5,963 shares worth $753K. The position accounts for 0.17% of the portfolio, ranked #119.
Wellington Shields & Co first reported a position in GILD in Q2 2014 and has held it in 34 quarters since. The position peaked at $915K in Q2 2019. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Wellington Shields & Co held 5,963 shares of Gilead Sciences worth $753K as of Q2 2026.
- Wellington Shields & Co sold 47 Gilead Sciences shares in Q2 2026, an estimated $6.19K.
- Gilead Sciences made up 0.17% of Wellington Shields & Co's portfolio in Q2 2026, its #119 holding.
- Wellington Shields & Co first reported a position in Gilead Sciences in Q2 2014 and has held it in 34 quarters since.
- Wellington Shields & Co's Gilead Sciences position peaked at $915K in Q2 2019.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.